These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6525804)

  • 1. The bleeding time: current practice in the UK.
    Poller L; Thomson JM; Tomenson JA
    Clin Lab Haematol; 1984; 6(4):369-73. PubMed ID: 6525804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006.
    Jennings I; Woods TA; Kitchen S; Walker ID
    J Clin Pathol; 2008 Aug; 61(8):950-4. PubMed ID: 18663056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current practices of bleeding time in a developing country: an alert for noncompliance with the standard procedures.
    Tantanate C; Tientadakul P
    Int J Lab Hematol; 2014 Feb; 36(1):77-82. PubMed ID: 23889816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. I. Normal values, application in thrombocytopenic patients and evaluation of heparin and aspirin effects.
    Janzarik H; Remy S; Morell S; Pabst W
    Blut; 1986 Jun; 52(6):345-56. PubMed ID: 3719109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standardization of bleeding time by IVY method in male Japanese healthy volunteers].
    Ikeda Y; Kondo K; Umemura K
    Rinsho Byori; 2005 Apr; 53(4):275-8. PubMed ID: 15915761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized and blinded comparison of the sensitivity and the reproducibility of the Ivy and Simplate II bleeding time techniques.
    Koster T; Caekebeke-Peerlinck KM; Briet E
    Am J Clin Pathol; 1989 Sep; 92(3):315-20. PubMed ID: 2672778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. II. Application in bleeding disorders.
    Janzarik H; Heinrich D; Bödeker RH; Lasch HG
    Blut; 1988 Sep; 57(3):111-6. PubMed ID: 3262003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
    Ridefelt P; Egberg N; Hillarp A; Lethagen S; Tengborn L
    Lakartidningen; 2001 Sep; 98(37):3922-4. PubMed ID: 11586831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the sensitivity of 3 bleeding time techniques.
    Bain B; Forster T; Baker A
    Scand J Haematol; 1983 Apr; 30(4):311-6. PubMed ID: 6857147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories.
    Jennings I; Kitchen S; Menegatti M; Palla R; Walker I; Makris M; Peyvandi F
    Int J Lab Hematol; 2017 Aug; 39(4):350-358. PubMed ID: 28406553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
    Favaloro EJ
    J Thromb Haemost; 2004 Dec; 2(12):2280-2; author reply 2283-5. PubMed ID: 15613055
    [No Abstract]   [Full Text] [Related]  

  • 12. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.
    Quiroga T; Goycoolea M; Muñoz B; Morales M; Aranda E; Panes O; Pereira J; Mezzano D
    J Thromb Haemost; 2004 Jun; 2(6):892-8. PubMed ID: 15140124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of MRI quality assurance programmes.
    Koller CJ; Eatough JP; Mountford PJ; Frain G
    Br J Radiol; 2006 Jul; 79(943):592-6. PubMed ID: 16823064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis].
    Thommen D; Sulzer I; Buhrfeind E; Naef R; Furlan M; Lämmle B
    Schweiz Med Wochenschr; 1988 Oct; 118(43):1559-67. PubMed ID: 3238391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of variables affecting the bleeding time using two disposable devices.
    Buchanan GR; Holtkamp CA
    Am J Clin Pathol; 1989 Jan; 91(1):45-51. PubMed ID: 2910014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association.
    Moffat KA; Ledford-Kraemer MR; Nichols WL; Hayward CP;
    Thromb Haemost; 2005 Mar; 93(3):549-53. PubMed ID: 15735808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of bleeding time using simplate--comparison with the Duke method].
    Harada K; Kawai Y
    Rinsho Byori; 1982 Dec; 30(12):1379-83. PubMed ID: 7161907
    [No Abstract]   [Full Text] [Related]  

  • 19. Whither ophthalmic pathology in the UK: why not wither and whemmie?
    Parsons MA
    Eye (Lond); 2001 Oct; 15(Pt 5):565-7. PubMed ID: 11702963
    [No Abstract]   [Full Text] [Related]  

  • 20. Bleeding time: an unreliable predictor of clinical hemostasis.
    De Rossi SS; Glick M
    J Oral Maxillofac Surg; 1996 Sep; 54(9):1119-20. PubMed ID: 8811825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.